DOI:
10.1055/s-00000099
Zeitschrift für Orthopädie und Unfallchirurgie
LinksClose Window
References
Confavreux C, OʼConnor P, Comi G. et al.
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Neurol 2014;
13: 247-256
doi:10.1016/S1474-4422(13)70308-9
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.